OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up
Autor: | Cuppens, K., Baas, P., Wiesweg, M., Du Pont, B., Ploenes, T., Theegarten, D., Aigner, C., Hartemink, K., Maes, B., Pat, K., Schuler, M. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2024 19(10) Supplement:S9-S9 |
Databáze: | ScienceDirect |
Externí odkaz: |